Bicara Therapeutics Inc. (BCAX)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch BCAX
Latest sale
$401k
Sep 8 · Routine
Form 4 sales
44
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    May 21 2026

    Sold 9,200 shares at $20.42 ($188k)

    Hyep Ivan, Chief Financial Officer

    10b5-1 planSold 6% of holdings ($3.2M position)145,355 shares left1x usual sizeFiling

  2. 2 Form 4 saleUnusual
    Jul 8 +48 days

    Sold 28,000 shares at $28.84 ($808k)

    Hyep Ivan, Chief Financial Officer

    10b5-1 planSold 17.7% of holdings ($4.6M position)129,855 shares left3x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Jul 9 +1 day

    Sold 28,750 shares at $28.98 ($833k)

    Cohlhepp Ryan, President and COO

    10b5-1 planSold 13.7% of holdings ($6.1M position)181,641 shares left2.3x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Jul 10 +1 day

    Sold 10,000 shares at $28.42 ($284k)

    Mazumdar Claire, Chief Executive Officer

    10b5-1 planSold 2.7% of holdings ($10.6M position)362,152 shares left0.5x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Aug 10 +31 days

    Sold 18,750 shares at $27.98 ($525k)

    Cohlhepp Ryan, President and COO

    10b5-1 planSold 9.4% of holdings ($5.6M position)181,641 shares left1.5x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Aug 10 same day

    Sold 10,000 shares at $27.98 ($280k)

    Mazumdar Claire, Chief Executive Officer

    10b5-1 planSold 2.7% of holdings ($10.4M position)362,152 shares left0.7x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Aug 10 same day

    Sold 12,500 shares at $27.97 ($350k)

    Hyep Ivan, Chief Financial Officer

    10b5-1 planSold 8.8% of holdings ($4M position)129,855 shares left1.4x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Sep 8 +29 days

    Sold 17,500 shares at $22.90 ($401k)

    Cohlhepp Ryan, President, COO & Interim CEO

    10b5-1 planSold 8.8% of holdings ($4.6M position)181,641 shares left1.4x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (44)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for BCAX
Source
Sep 8, 2026Cohlhepp RyanPresident, COO & Interim CEOForm 4 sale17,500$401k8.8%RoutineSEC
Aug 10, 2026Hyep IvanChief Financial OfficerForm 4 sale12,500$350k8.8%RoutineSEC
Aug 10, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale10,000$280k2.7%RoutineSEC
Aug 10, 2026Cohlhepp RyanPresident and COOForm 4 sale18,750$525k9.4%RoutineSEC
Jul 10, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale10,000$284k2.7%RoutineSEC
Jul 9, 2026Cohlhepp RyanPresident and COOForm 4 sale28,750$833k13.7%RoutineSEC
Jul 8, 2026Hyep IvanChief Financial OfficerForm 4 sale28,000$808k17.7%UnusualSEC
May 21, 2026Hyep IvanChief Financial OfficerForm 4 sale9,200$188k6.0%RoutineSEC
May 18, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale15,000$301k4.0%RoutineSEC
May 15, 2026Cohlhepp RyanPresident and COOForm 4 sale12,500$254k6.1%RoutineSEC
Apr 27, 2026Raben DavidChief Medical OfficerForm 4 sale5,500$126k9.0%RoutineSEC
Apr 21, 2026Hyep IvanChief Financial OfficerForm 4 sale9,200$212k6.0%RoutineSEC
Apr 20, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale15,000$354k4.0%RoutineSEC
Apr 15, 2026Cohlhepp RyanPresident and COOForm 4 sale12,500$288k6.0%RoutineSEC
Mar 25, 2026Raben DavidChief Medical OfficerForm 4 sale5,500$104k9.0%RoutineSEC
Mar 23, 2026Hyep IvanChief Financial OfficerForm 4 sale9,200$170k6.0%RoutineSEC
Mar 20, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale15,000$282k4.2%RoutineSEC
Mar 16, 2026Cohlhepp RyanPresident and COOForm 4 sale12,500$246k5.9%RoutineSEC
Mar 9, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale36,766$705k9.8%RoutineSEC
Mar 6, 2026Mazumdar ClaireChief Executive OfficerForm 4 sale8,234$154k2.4%RoutineSEC
Mar 4, 2026Hyep IvanChief Financial OfficerForm 4 sale16,518$301k10.2%RoutineSEC
Mar 4, 2026Raben DavidChief Medical OfficerForm 4 sale16,500$306k23.0%RoutineSEC
Mar 3, 2026Cohlhepp RyanPresident and COOForm 4 sale17,392$316k7.8%RoutineSEC
Feb 25, 2026Cohlhepp RyanPresident and COOForm 4 sale3,631$66k1.7%RoutineSEC
Jan 22, 2026Cohlhepp RyanPresident and COOForm 4 sale3,828$69k1.8%RoutineSEC
Jan 22, 2026Hyep IvanChief Financial OfficerForm 4 sale1,882$34k1.3%RoutineSEC
Jan 15, 2026Cohlhepp RyanPresident and COOForm 4 sale149$3k0.1%RoutineSEC
Dec 22, 2025Hyep IvanChief Financial OfficerForm 4 sale9,200$168k6.0%RoutineSEC
Dec 15, 2025Cohlhepp RyanPresident and COOForm 4 sale12,500$234k6.2%RoutineSEC
Nov 25, 2025Raben DavidChief Medical OfficerForm 4 sale11,000$205k23.7%RoutineSEC
Nov 24, 2025Mazumdar ClaireChief Executive OfficerForm 4 sale41,163$776k11.7%RoutineSEC
Nov 24, 2025Hyep IvanChief Financial OfficerForm 4 sale18,400$341k11.2%RoutineSEC
Nov 21, 2025Cohlhepp RyanPresident and COOForm 4 sale12,500$226k6.1%RoutineSEC
Oct 16, 2025Mazumdar ClaireChief Executive OfficerForm 4 sale24,103$454k7.2%RoutineSEC
Oct 15, 2025Cohlhepp RyanPresident and COOForm 4 sale12,500$227k5.9%RoutineSEC
Oct 15, 2025Mazumdar ClaireChief Executive OfficerForm 4 sale24,734$467k7.4%RoutineSEC
Oct 9, 2025Raben DavidChief Medical OfficerForm 4 sale22,000$406k38.3%RoutineSEC
Oct 9, 2025Hyep IvanChief Financial OfficerForm 4 sale6,415$117k4.2%RoutineSEC
Oct 8, 2025Hyep IvanChief Financial OfficerForm 4 sale30,385$553k17.3%RoutineSEC
Oct 7, 2025Cohlhepp RyanPresident and COOForm 4 sale50,500$912k19.9%RoutineSEC
Sep 29, 2025Meisner LaraChief Legal OfficerForm 4 sale33,807$499k100.0%RoutineSEC
Sep 15, 2025Meisner LaraChief Legal OfficerForm 4 sale15,829$182k100.0%RoutineSEC
Jun 16, 2025Meisner LaraChief Legal OfficerForm 4 sale15,829$165k100.0%RoutineSEC
Mar 14, 2025Meisner LaraChief Legal OfficerForm 4 sale79,146$1M100.0%RoutineSEC